NORLIQVA
- Product NDC
- 46287-037
- 11-digit product format
- 462870037
- Labeler code
- 46287
- Product ID
- 46287-037_4fee8eba-2fa2-4a9c-884a-ccec171e1977
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- amlodipine
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- CMP Pharma, Inc.
- Application
- NDA214439
- Marketing category
- NDA
- Marketing start
- 2026-03-02
- Substance
- AMLODIPINE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NORLIQVA
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| AMLODIPINE | 1 mg/mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 1J444QC288 |
| Rxcui | 2599173, 2599179 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fa898d56-9495-d6f0-309b-68a5d8e3914a | Product name | 4 | 20260305 |
| c19ec24d-2c40-4b8d-7c20-500ffa3660a1 | Product name | 3 | 20260303 |
| b15e9aa6-d523-ca97-480e-570e0543a342 | Product name | 4 | 20251024 |
| 265792b3-b999-c010-7364-a7db20b9d4d9 | Product name | 5 | 20250515 |
| 14c2c15b-f823-4ada-a40e-a440544294dc | Product name | 1 | 20221207 |
| a72887ef-d675-499f-af4b-78688f6855cd | Product name | 1 | 20191002 |
| a4484670-2869-6416-f6ff-03b1b3cbd1b0 | Product name | 2 | 20190415 |
| 4a27501f-a987-48a5-99b4-e983d4744d76 | Product name | 7 | 20181211 |
| 18600d07-613d-bf9c-2711-fe40c06f3393 | Product name | 5 | 20180703 |
| bded1554-44de-900a-5297-403365d6d4b2 | Product name | 3 | 20170110 |
| 1f1c6e4b-bbad-4649-afd1-7a1d671db4b1 | Product name | 1 | 20150316 |
| 63ab5fbf-2a6b-c41d-051a-39e845d718b1 | Product name | 1 | 20140508 |
| 7613b1a5-acb6-4e5e-6048-c44deeeb1212 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 46287-037-01 | NORLIQVA | 150 mL in 1 BOTTLE | Solution | 150 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 46287-037-01 | ML - Milliliter | 46287-037 | c72163f9-08e8-43d9-9183-0df6470aa272 | 1 | 2026-04-20 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2599173 | amLODIPine 1 MG/mL Oral Solution | PSN | 614d974f-51c7-4b18-8171-39eb6e8d4c03 | 2 |
| 2599179 | Norliqva 1 MG/mL Oral Solution | PSN | 614d974f-51c7-4b18-8171-39eb6e8d4c03 | 2 |
| 2599179 | amlodipine 1 MG/ML Oral Solution [Norliqva] | SBD | 614d974f-51c7-4b18-8171-39eb6e8d4c03 | 2 |
| 2599173 | amlodipine 1 MG/ML Oral Solution | SCD | 614d974f-51c7-4b18-8171-39eb6e8d4c03 | 2 |
| 2599173 | amlodipine 1 MG (as amlodipine besylate 1.385 MG) per ML Oral Solution | SY | 614d974f-51c7-4b18-8171-39eb6e8d4c03 | 2 |
| 2599179 | Norliqva 1 MG (as amlodipine besylate 1.385 MG) per 1 ML Oral Solution | SY | 614d974f-51c7-4b18-8171-39eb6e8d4c03 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 46287-037-01 | 46287003701 | 150 mL in 1 BOTTLE (46287-037-01) | 150 ml | 2026-03-02 | No | No | Historical |